The Impact of a 1-Day Multidisciplinary Prostate Cancer Clinic on Patients ’ Choice of Treatment

Prostate cancer is the most common solid malignancy in men in the United States, affecting an estimated 240,000 men each year [1]. Fortunately, it is typically a slow-progressing cancer, and only approximately 14% of men with prostate cancer will die from the disease [2]. There is no clear evidence demonstrating improved survival from definitive treatment in patients with low-risk prostate cancer, which has led to controversy in how to best manage this group [2]. The National Comprehensive Cancer  Network treatment recommendations for low-risk prostate cancer with a life expectancy of 10 or more years include active surveillance (prostate-specific antigen monitoring, yearly digital rectal examination, and biopsy), external-beam radiation therapy, brachytherapy, or even radical prostatectomy [3].
Source: Journal of the American College of Radiology : JACR - Category: Radiology Authors: Tags: Case studies in clinical practice management Source Type: research